Johnson & Johnson Reports 2018 Fourth-Quarter Results:

Go back to Johnson & Johnson Reports 2018 Fourth-Quarter Results:

Johnson & Johnson (JNJ) PT Lowered to $145 at Raymond James

January 23, 2019 7:38 AM EST

Raymond James analyst Jayson Bedford lowered the price target on Johnson & Johnson (NYSE: JNJ) to $145.00 (from $149.00) while maintaining a Outperform rating.

... More

Johnson & Johnson (JNJ) PT Lowered to $144 at RBC Capital

January 23, 2019 6:53 AM EST

RBC Capital analyst Glenn Novarro lowered the price target on Johnson & Johnson (NYSE: JNJ) to $144.00 (from $155.00) while maintaining a Outperform rating.

Novarro notes management has set conservative 2019 guidance. As such, he expects the 'beat and raises' to continue.

... More

Johnson & Johnson (JNJ) Tops Q4 EPS by 2c, Offers FY Guidance

January 22, 2019 6:41 AM EST

Johnson & Johnson (NYSE: JNJ) reported Q4 EPS of $1.97, $0.02 better than the analyst estimate of $1.95. Revenue for the quarter came in at $20.4 billion versus the consensus estimate of $20.17 billion.

GUIDANCE:

Johnson & Johnson sees FY2019 EPS of $8.50-$8.65, versus the consensus of $8.61.... More